JORGENSEN FENTON LTD
Executive Summary
JORGENSEN FENTON LTD shows strong financial health with solid liquidity, growing net assets, and controlled liabilities typical of a well-managed micro-entity medical practice. The company is in a stable growth phase with no signs of financial distress. Maintaining vigilant cash flow management and proactive financial planning will support sustainable expansion and long-term resilience.
View Full Analysis Report →Company Documents
| Date | Description |
|---|---|
| 27/01/2527 January 2025 | Confirmation statement made on 2025-01-12 with no updates |
| 24/09/2424 September 2024 | Micro company accounts made up to 2024-01-31 |
| 31/01/2431 January 2024 | Annual accounts for year ending 31 Jan 2024 |
| 18/01/2418 January 2024 | Confirmation statement made on 2024-01-12 with no updates |
| 16/10/2316 October 2023 | Micro company accounts made up to 2023-01-31 |
| 31/01/2331 January 2023 | Annual accounts for year ending 31 Jan 2023 |
| 12/01/2312 January 2023 | Appointment of Dr Matthew James Fenton as a director on 2023-01-12 |
| 12/01/2312 January 2023 | Confirmation statement made on 2023-01-12 with no updates |
| 16/01/2216 January 2022 | Incorporation |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company